These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 9121364

  • 1. In vivo consequences of M1-receptor activation by talsaclidine.
    Walland A, Burkard S, Hammer R, Tröger W.
    Life Sci; 1997; 60(13-14):977-84. PubMed ID: 9121364
    [Abstract] [Full Text] [Related]

  • 2. Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs.
    Walland A, Palluk R, Burkard S, Hammer R.
    Eur J Pharmacol; 1997 Jul 09; 330(2-3):213-9. PubMed ID: 9253956
    [Abstract] [Full Text] [Related]

  • 3. Central activation of the sympathetic nervous system including the adrenals in anaesthetized guinea pigs by the muscarinic agonist talsaclidine.
    Walland A, Pieper MP.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr 09; 357(4):426-30. PubMed ID: 9606029
    [Abstract] [Full Text] [Related]

  • 4. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
    Terry AV, Buccafusco JJ, Borsini F, Leusch A.
    Psychopharmacology (Berl); 2002 Jul 09; 162(3):292-300. PubMed ID: 12122487
    [Abstract] [Full Text] [Related]

  • 5. Functional characterization of peripheral muscarinic subtypes in anesthetized cats.
    Koss MC.
    Life Sci; 1997 Jul 09; 61(2):217-27. PubMed ID: 9217280
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain.
    Müller DM, Mendla K, Farber SA, Nitsch RM.
    Life Sci; 1997 Jul 09; 60(13-14):985-91. PubMed ID: 9121365
    [Abstract] [Full Text] [Related]

  • 7. WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties.
    Ensinger HA, Doods HN, Immel-Sehr AR, Kuhn FJ, Lambrecht G, Mendla KD, Müller RE, Mutschler E, Sagrada A, Walther G.
    Life Sci; 1993 Jul 09; 52(5-6):473-80. PubMed ID: 8441328
    [Abstract] [Full Text] [Related]

  • 8. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase.
    Wotta DR, Wattenberg EV, Langason RB, el-Fakahany EE.
    Pharmacology; 1998 Apr 09; 56(4):175-86. PubMed ID: 9566019
    [Abstract] [Full Text] [Related]

  • 9. Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man.
    Wienrich M, Meier D, Ensinger HA, Gaida W, Raschig A, Walland A, Hammer R.
    Life Sci; 2001 Apr 27; 68(22-23):2593-600. PubMed ID: 11392631
    [Abstract] [Full Text] [Related]

  • 10. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
    Wood MD, Murkitt KL, Ho M, Watson JM, Brown F, Hunter AJ, Middlemiss DN.
    Br J Pharmacol; 1999 Apr 27; 126(7):1620-4. PubMed ID: 10323594
    [Abstract] [Full Text] [Related]

  • 11. Effects of central muscarinic-1 receptor stimulation on blood pressure regulation.
    Medina A, Bodick N, Goldberger AL, Mac Mahon M, Lipsitz LA.
    Hypertension; 1997 Mar 27; 29(3):828-34. PubMed ID: 9052903
    [Abstract] [Full Text] [Related]

  • 12. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
    Akam EC, Challiss RA, Nahorski SR.
    Br J Pharmacol; 2001 Feb 27; 132(4):950-8. PubMed ID: 11181437
    [Abstract] [Full Text] [Related]

  • 13. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
    Züchner T, Perez-Polo JR, Schliebs R.
    J Neurosci Res; 2004 Jul 15; 77(2):250-7. PubMed ID: 15211591
    [Abstract] [Full Text] [Related]

  • 14. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
    Pei XF, Gupta TH, Badio B, Padgett WL, Daly JW.
    J Med Chem; 1998 Jun 04; 41(12):2047-55. PubMed ID: 9622546
    [Abstract] [Full Text] [Related]

  • 15. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J, Lembøl HL, Meier E, Pedersen H.
    Eur J Pharmacol; 1992 Jul 21; 218(1):159-69. PubMed ID: 1397027
    [Abstract] [Full Text] [Related]

  • 16. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM, Bromidge SM, Brown F, Clark MS, Hatcher JP, Hawkins J, Riley GJ, Noy G, Orlek BS.
    J Pharmacol Exp Ther; 1997 Dec 21; 283(3):1059-68. PubMed ID: 9399977
    [Abstract] [Full Text] [Related]

  • 17. M1 muscarinic receptor signaling in mouse hippocampus and cortex.
    Porter AC, Bymaster FP, DeLapp NW, Yamada M, Wess J, Hamilton SE, Nathanson NM, Felder CC.
    Brain Res; 2002 Jul 19; 944(1-2):82-9. PubMed ID: 12106668
    [Abstract] [Full Text] [Related]

  • 18. Muscarinic M1 receptor activation reduces maximum upstroke velocity of action potential in mouse right atria.
    Islam MA, Nojima H, Kimura I.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):227-36. PubMed ID: 9652364
    [Abstract] [Full Text] [Related]

  • 19. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P.
    J Pharmacol Exp Ther; 1997 May 10; 281(2):868-75. PubMed ID: 9152396
    [Abstract] [Full Text] [Related]

  • 20. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
    Olianas MC, Maullu C, Onali P.
    Neuropsychopharmacology; 1999 Mar 10; 20(3):263-70. PubMed ID: 10063486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.